External validation of a PCA-3-based nomogram for predicting prostate cancer and high-grade cancer on initial prostate biopsy.
about
Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.The role of prostate cancer biomarkers in undiagnosed men.Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.
P2860
External validation of a PCA-3-based nomogram for predicting prostate cancer and high-grade cancer on initial prostate biopsy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
External validation of a PCA-3 ...... er on initial prostate biopsy.
@en
type
label
External validation of a PCA-3 ...... er on initial prostate biopsy.
@en
prefLabel
External validation of a PCA-3 ...... er on initial prostate biopsy.
@en
P2093
P2860
P356
P1433
P1476
External validation of a PCA-3 ...... cer on initial prostate biopsy
@en
P2093
Ahmed Elshafei
Daniel J Greene
Ercan Malkoc
J Stephen Jones
Onder Kara
Tianming Gao
P2860
P304
P356
10.1002/PROS.23197
P50
P577
2016-05-16T00:00:00Z